Assenagon Asset Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $390K | Sell |
|
|||||
|
2024
Q3 | $479K | Sell |
|
|||||
|
2024
Q2 | $1.77M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $29.8M | Buy |
|
|||||
|
2023
Q3 | $1.1M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $131K | Sell |
|
|||||
|
2022
Q4 | $2.05M | Sell |
|
|||||
|
2022
Q3 | $1.46M | Hold |
|
|||||
|
2022
Q2 | $1.11M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $999K | Buy |
|
|||||
|
2021
Q3 | $831K | Sell |
|
|||||
|
2021
Q2 | $2.8M | Sell |
|
|||||
|
2021
Q1 | $20.8M | Sell |
|
|||||
|
2020
Q4 | $16.5M | Sell |
|
|||||
|
2020
Q3 | $8.59M | Sell |
|
|||||
|
2020
Q2 | $3.41M | Sell |
|
|||||
|
2020
Q1 | $4.69M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $5.06M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $861K | Buy |
|